Literature DB >> 11682267

A commentary on the neurobiology of the hypocretin/orexin system.

E Mignot1.   

Abstract

Hypocretins/orexins are rapidly emerging as functionally important neurotransmitters. Two related neuropeptides (Hcrt-1/OXA, Hcrt-2/OXB) encoded by the same precursor gene and two G-protein coupled receptors (Hcrtr1/OXR1, Hcrtr2/OXR2) are currently known. Hypocretin-containing cells are discretely localized within the perifornical hypothalamus but have widespread projections, with generally excitatory postsynaptic effects. Dense excitatory projections to all monoaminergic cell groups have been reported. A major emerging function for this system is likely to be the regulation of sleep. Alterations in hypocretin neurotransmission causes the sleep disorder narcolepsy in mice, dogs and humans. Effects on appetite, neuroendocrine and energy metabolism regulation are also suggested by other studies. Hypocretins are uniquely positioned to link sleep, appetite and neuroendocrine control, three behaviors of major importance in psychiatry. The potential role of this system in regulating the sleep cycle, modulating wakefulness at selected circadian times and in mediating the deleterious effects of sleep deprivation is discussed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11682267     DOI: 10.1016/S0893-133X(01)00316-5

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  13 in total

Review 1.  Hepatic encephalopathy and sleepiness: an interesting connection?

Authors:  Sara Montagnese; Matteo Turco; Piero Amodio
Journal:  J Clin Exp Hepatol       Date:  2014-06-29

2.  Knockdown of orexin type 1 receptor in rat locus coeruleus increases REM sleep during the dark period.

Authors:  Lichao Chen; James T McKenna; Yunren Bolortuya; Stuart Winston; Mahesh M Thakkar; Radhika Basheer; Ritchie E Brown; Robert W McCarley
Journal:  Eur J Neurosci       Date:  2010-11       Impact factor: 3.386

3.  Centrally administered orexin A increases motivation for sweet pellets in rats.

Authors:  A J Thorpe; J P Cleary; A S Levine; C M Kotz
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

4.  Effects of rapid eye movement sleep deprivation on hypocretin neurons in the hypothalamus of a rat model of depression.

Authors:  Joanne S Allard; Yousef Tizabi; James P Shaffery; Kebreten Manaye
Journal:  Neuropeptides       Date:  2007-06-27       Impact factor: 3.286

5.  Narcolepsy - Between the dream and reality.

Authors:  Fernando Morgadinho Santos Coelho
Journal:  Sleep Sci       Date:  2014-08-19

6.  CDH13 and HCRTR2 May Be Associated with Hypersomnia Symptom of Bipolar Depression: A Genome-Wide Functional Enrichment Pathway Analysis.

Authors:  Chul-Hyun Cho; Heon-Jeong Lee; Hyun Goo Woo; Ji-Hye Choi; Tiffany A Greenwood; John R Kelsoe
Journal:  Psychiatry Investig       Date:  2015-07-06       Impact factor: 2.505

7.  Inhibition of orexin-1/hypocretin-1 receptors inhibits yohimbine-induced reinstatement of ethanol and sucrose seeking in Long-Evans rats.

Authors:  Jemma K Richards; Jeffrey A Simms; Pia Steensland; Sharif A Taha; Stephanie L Borgland; Antonello Bonci; Selena E Bartlett
Journal:  Psychopharmacology (Berl)       Date:  2008-05-10       Impact factor: 4.530

8.  Locus Coeruleus, norepinephrine and Aβ peptides in Alzheimer's disease.

Authors:  Jennifer A Ross; Paul McGonigle; Elisabeth J Van Bockstaele
Journal:  Neurobiol Stress       Date:  2015

9.  Neural circuit interactions between the dorsal raphe nucleus and the lateral hypothalamus: an experimental and computational study.

Authors:  Jaishree Jalewa; Alok Joshi; T Martin McGinnity; Girijesh Prasad; KongFatt Wong-Lin; Christian Hölscher
Journal:  PLoS One       Date:  2014-02-06       Impact factor: 3.240

10.  Predicting gene ontology annotations of orphan GWAS genes using protein-protein interactions.

Authors:  Usha Kuppuswamy; Seshan Ananthasubramanian; Yanli Wang; Narayanaswamy Balakrishnan; Madhavi K Ganapathiraju
Journal:  Algorithms Mol Biol       Date:  2014-04-03       Impact factor: 1.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.